Pandemics can have crippling effects on global markets, with the cessation of everyday activities often felt most acutely in already at-risk population, including cancer patients. Though the European travel ban has been enacted to curb the spread of the coronavirus, this same ban threatened the highly time-sensitive delivery of Novaris’ Kymriah gene therapy to those in need overseas. Luckily, Novartis found alternative shipping methods in time, however, if they had not, the results could have been catastrophic. Yourway is a premium courier for drug product shipments. As such, we can guarantee delivery of all sensitive clinical materials even when faced with adversity and are a safe option for all pharma companies in similar situations.